Price History
Feb 9, 2026 — Mar 31, 2026Investment Snapshot
- P/B of 7.64 — trading above book value
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -256.5%
- Revenue growing at 28% annually
MDxHealth SA - Ordinary Shares (MDXH) is a Healthcare company operating in Services-Medical Laboratories, listed on the NASDAQ , with a market capitalisation of $113 million . Key value metrics: P/B ratio 7.64, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
MDxHealth SA - Ordinary Shares — Fundamental Analysis Summary
On financial health, MDXH shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -256.5% (sector average: -19.8%), and high leverage with a debt-to-equity ratio of 2.40.
StockPik's composite Value Score for MDXH is 25/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MDXH reports a high gross margin of 61.2% (sector average: 33.5%) and a negative operating margin of -27.5%.
MDXH shows revenue growing at 28% year-over-year, with earnings growing at 12%.